REVIEW An atypical antipsychotic. Ziprasidone's affinities for most of the dopamine and serotonin receptors and the a1-adrenergic receptor are high and its affinity for the histamine H1 receptor is moderate.
Pappadopulos E, Newcomer JW, Kolluri S (2012). Changes in weight, plasma lipids, and glucose in adults treated with ziprasidone: a comprehensive analysis of pfizer-initiated clinical trials. J Clin Psychiatry. 73(6):e742-8. PMID 22795213.
Park S, Kim MS, Namkoong C, Park MH, Hong JP (2012). The effect of ziprasidone on body weight and energy expenditure in female rats. Metabolism. 61(6):787-93. PMID 22209671.
These chemical products are for research and development use only. They are not for diagnostic, therapeutic, cosmetic, or human and animal uses. They are not sold to individuals. Additional restrictions may apply.
New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. CATEGORIES APIs and Bioactives > Dopamine Antagonists, Antipsychotics